Although there is evidence of biomarkers associated with the insulin pathway, some researchers challenge the view that the insulin signaling pathway is the primary factor in macrosomia development and instead propose alternative mechanisms for fetal growth in GDM and normoglycemic mothers [38,111]. The gene discussed is INS; the disease is gestational diabetes.